American Century Companies’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.91M Buy
141,092
+27,456
+24% +$1.43M ﹤0.01% 1680
2026
Q1
$5.45M Buy
113,636
+3,316
+3% +$145K ﹤0.01% 1740
2025
Q4
$4.26M Buy
110,320
+9,914
+10% +$378K ﹤0.01% 1796
2025
Q3
$3.54M Buy
100,406
+8,011
+9% +$290K ﹤0.01% 1858
2025
Q2
$3.33M Buy
92,395
+17,894
+24% +$593K ﹤0.01% 1846
2025
Q1
$2.32M Buy
74,501
+7,341
+11% +$233K ﹤0.01% 1928
2024
Q4
$1.71M Buy
67,160
+3,671
+6% +$97.3K ﹤0.01% 2053
2024
Q3
$1.8M Buy
63,489
+3,021
+5% +$83.7K ﹤0.01% 1998
2024
Q2
$1.59M Buy
60,468
+6,955
+13% +$193K ﹤0.01% 1988
2024
Q1
$1.63M Buy
53,513
+8,809
+20% +$260K ﹤0.01% 1960
2023
Q4
$1.26M Buy
44,704
+2,106
+5% +$57.9K ﹤0.01% 1976
2023
Q3
$1.16M Buy
42,598
+1,627
+4% +$48.3K ﹤0.01% 1941
2023
Q2
$1.26M Buy
40,971
+837
+2% +$28.3K ﹤0.01% 1840
2023
Q1
$1.45M Buy
40,134
+5,931
+17% +$220K ﹤0.01% 1732
2022
Q4
$1.35M Buy
34,203
+10,063
+42% +$420K ﹤0.01% 1697
2022
Q3
$970K Buy
24,140
+15,634
+184% +$668K ﹤0.01% 1704
2022
Q2
$358K Buy
+8,506
New +$349K ﹤0.01% 2015

Other funds holding RPRX

American Century Companies's RPRX Position: Q2 2026 in Review

American Century Companies increased its Royalty Pharma (RPRX) stake by 24% in Q2 2026, buying an estimated $1.43M and bringing the position to 141,092 shares worth $7.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

American Century Companies first reported a position in RPRX in Q2 2022 and has held it in 17 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • American Century Companies held 141,092 shares of Royalty Pharma worth $7.91M as of Q2 2026.
  • American Century Companies bought 27,456 Royalty Pharma shares in Q2 2026, an estimated $1.43M.
  • Royalty Pharma made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1680 holding.
  • American Century Companies first reported a position in Royalty Pharma in Q2 2022 and has held it in 17 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.